Details of the Drug

General Information of Drug (ID: DMOI9EL)

Drug Name
Radezolid
Synonyms
Radezolid; Radezolid hydrochloride; RX-103; RX-1741; RX-01-667; Oxazolidinone antibiotic (bacterial infection), Rib-X Pharmaceuticals; Oxazolidinone antibiotic (CAP/uSSSI), Rib-X Pharamceuticals; Radezolid (iv, gram positive bacterial infection), Rib-X Pharmaceuticals; RX-1741 (iv, gram positive bacterial infection), Rib-X Pharmaceuticals; Radezolid (oral, CAP/uSSSI), Rib-X Pharmaceuticals; RX-1741 (oral, CAP/uSSSI), Rib-X Pharmaceuticals
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Phase 2 [1]
Pneumonia CA40 Phase 2 [2]
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
11224409
UNII
53PC6LO35W
DrugBank ID
DB12339
TTD ID
D0W5PN
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Protein synthesis (Bact PROS) TT2VX74 NOUNIPROTAC Inhibitor [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00640926) Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia. U.S. National Institutes of Health.
3 Antibiotics in the clinical pipeline in 2011. J Antibiot (Tokyo). 2011 Jun;64(6):413-25.